List of Tables
Table 1. Global Plasma Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Plasma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Plasma Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Plasma Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Plasma Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Plasma Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Plasma Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Plasma Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Plasma Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Plasma Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Plasma Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Plasma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Therapy as of 2024)
Table 15. Global Plasma Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Plasma Therapy Market
Table 17. Global Plasma Therapy Companies Product & Service
Table 18. Global Plasma Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Terumo Corporation Information
Table 20. Terumo Description and Business Overview
Table 21. Terumo Plasma Therapy Product
Table 22. Terumo Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Terumo Revenue Proportion of Plasma Therapy by Product in 2024
Table 24. Terumo Revenue Proportion of Plasma Therapy by Application in 2024
Table 25. Terumo Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 26. Terumo Recent Developments
Table 27. Arthrex Corporation Information
Table 28. Arthrex Description and Business Overview
Table 29. Arthrex Plasma Therapy Product
Table 30. Arthrex Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Arthrex Revenue Proportion of Plasma Therapy by Product in 2024
Table 32. Arthrex Revenue Proportion of Plasma Therapy by Application in 2024
Table 33. Arthrex Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 34. Arthrex Recent Developments
Table 35. Zimmer Biomet Corporation Information
Table 36. Zimmer Biomet Description and Business Overview
Table 37. Zimmer Biomet Plasma Therapy Product
Table 38. Zimmer Biomet Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Zimmer Biomet Revenue Proportion of Plasma Therapy by Product in 2024
Table 40. Zimmer Biomet Revenue Proportion of Plasma Therapy by Application in 2024
Table 41. Zimmer Biomet Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 42. Zimmer Biomet Recent Developments
Table 43. DePuy Synthes Corporation Information
Table 44. DePuy Synthes Description and Business Overview
Table 45. DePuy Synthes Plasma Therapy Product
Table 46. DePuy Synthes Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. DePuy Synthes Revenue Proportion of Plasma Therapy by Product in 2024
Table 48. DePuy Synthes Revenue Proportion of Plasma Therapy by Application in 2024
Table 49. DePuy Synthes Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 50. DePuy Synthes Recent Developments
Table 51. EmCyte Corporation Information
Table 52. EmCyte Description and Business Overview
Table 53. EmCyte Plasma Therapy Product
Table 54. EmCyte Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. EmCyte Revenue Proportion of Plasma Therapy by Product in 2024
Table 56. EmCyte Revenue Proportion of Plasma Therapy by Application in 2024
Table 57. EmCyte Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 58. EmCyte Recent Developments
Table 59. Regen Lab Corporation Information
Table 60. Regen Lab Description and Business Overview
Table 61. Regen Lab Plasma Therapy Product
Table 62. Regen Lab Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Regen Lab Revenue Proportion of Plasma Therapy by Product in 2024
Table 64. Regen Lab Revenue Proportion of Plasma Therapy by Application in 2024
Table 65. Regen Lab Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 66. Regen Lab Recent Developments
Table 67. ISTO Biologics Corporation Information
Table 68. ISTO Biologics Description and Business Overview
Table 69. ISTO Biologics Plasma Therapy Product
Table 70. ISTO Biologics Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. ISTO Biologics Revenue Proportion of Plasma Therapy by Product in 2024
Table 72. ISTO Biologics Revenue Proportion of Plasma Therapy by Application in 2024
Table 73. ISTO Biologics Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 74. ISTO Biologics Recent Developments
Table 75. Cesca Therapeutics Corporation Information
Table 76. Cesca Therapeutics Description and Business Overview
Table 77. Cesca Therapeutics Plasma Therapy Product
Table 78. Cesca Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Cesca Therapeutics Revenue Proportion of Plasma Therapy by Product in 2024
Table 80. Cesca Therapeutics Revenue Proportion of Plasma Therapy by Application in 2024
Table 81. Cesca Therapeutics Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 82. Cesca Therapeutics Recent Developments
Table 83. Weigao Corporation Information
Table 84. Weigao Description and Business Overview
Table 85. Weigao Plasma Therapy Product
Table 86. Weigao Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Weigao Revenue Proportion of Plasma Therapy by Product in 2024
Table 88. Weigao Revenue Proportion of Plasma Therapy by Application in 2024
Table 89. Weigao Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 90. Weigao Recent Developments
Table 91. REV-MED Corporation Information
Table 92. REV-MED Description and Business Overview
Table 93. REV-MED Plasma Therapy Product
Table 94. REV-MED Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. REV-MED Revenue Proportion of Plasma Therapy by Product in 2024
Table 96. REV-MED Revenue Proportion of Plasma Therapy by Application in 2024
Table 97. REV-MED Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 98. REV-MED Recent Developments
Table 99. Nuo Therapeutics Corporation Information
Table 100. Nuo Therapeutics Description and Business Overview
Table 101. Nuo Therapeutics Plasma Therapy Product
Table 102. Nuo Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Nuo Therapeutics Revenue Proportion of Plasma Therapy by Product in 2024
Table 104. Nuo Therapeutics Revenue Proportion of Plasma Therapy by Application in 2024
Table 105. Nuo Therapeutics Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 106. Nuo Therapeutics Recent Developments
Table 107. North America Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Plasma Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Plasma Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 127. Plasma Therapy Key Raw Materials, Industry Status and Trend
Table 128. Plasma Therapy Key Raw Materials and Upstream Suppliers
Table 129. Plasma Therapy Clients Status and Trend
Table 130. Plasma Therapy Typical Clients
Table 131. Plasma Therapy Distributors
Table 132. Plasma Therapy Market Trends
Table 133. Plasma Therapy Market Drivers
Table 134. Plasma Therapy Market Challenges
Table 135. Plasma Therapy Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Therapy Product Picture
Figure 2. Global Plasma Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Plasma Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Pure PRP Product Picture
Figure 5. Leucocyte-rich PRP Product Picture
Figure 6. Leukocyte-rich Fibrin (L-PRF) Product Picture
Figure 7. Global Plasma Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Plasma Therapy Revenue Market Share by Application in 2024 & 2031
Figure 9. Orthopedic
Figure 10. Darmatology
Figure 11. Cardiac Muscle Injury
Figure 12. Dental
Figure 13. Nerve Injury
Figure 14. Plasma Therapy Report Years Considered
Figure 15. Global Plasma Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Plasma Therapy Market Size (2020-2031) & (US$ Million)
Figure 17. Global Plasma Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 18. Global Plasma Therapy Revenue Market Share by Region (2020-2031)
Figure 19. Global Plasma Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Global Plasma Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Pure PRP of Plasma Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 22. Leucocyte-rich PRP of Plasma Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 23. Leukocyte-rich Fibrin (L-PRF) of Plasma Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 24. Plasma Therapy Revenue Share by Company (2024)
Figure 25. Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Pure PRP Revenue Proportion by Company in 2024
Figure 27. Leucocyte-rich PRP Revenue Proportion by Company in 2024
Figure 28. Leukocyte-rich Fibrin (L-PRF) Revenue Proportion by Company in 2024
Figure 29. North America Plasma Therapy Revenue 2020-2031 (US$ Million)
Figure 30. North America Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 31. North America Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Plasma Therapy Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Plasma Therapy Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 36. Europe Plasma Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Plasma Therapy Revenue Market Share by Country (2020-2031)
Figure 38. Europe Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 39. Europe Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Plasma Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Plasma Therapy Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Plasma Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Plasma Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 48. Plasma Therapy Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Plasma Therapy Raw Materials by Region in 2024
Figure 50. Plasma Therapy Distribution Channels
Figure 51. Global Plasma Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Plasma Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
